Total Debt
$8M
Net Debt
-$1.05B
Apogee Therapeutics, Inc. currently has $8M in total debt. Net debt is -$1.05B after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
APGE • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.01 | 1.06 | -1.05Net Cash | 1.29 | 0.6% |
| 2025-12-31 | 0.01 | 0.73 | -0.72Net Cash | 0.94 | 0.9% |
| 2025-09-30 | 0.01 | 0.53 | -0.52Net Cash | 0.63 | 1.6% |
| 2025-06-30 | 0.01 | 0.51 | -0.49Net Cash | 0.66 | 1.6% |
| 2025-03-31 | 0.01 | 0.51 | -0.50Net Cash | 0.71 | 1.7% |
| 2024-12-31 | 0.01 | 0.52 | -0.51Net Cash | 0.75 | 1.6% |
| 2024-09-30 | 0.01 | 0.53 | -0.51Net Cash | 0.78 | 1.6% |
| 2024-06-30 | 0.00 | 0.68 | -0.67Net Cash | 0.80 | 0.5% |
| 2024-03-31 | 0.00 | 0.82 | -0.81Net Cash | 0.82 | 0.2% |
| 2023-12-31 | 0.00 | 0.40 | -0.39Net Cash | 0.40 | 0.5% |
| 2023-09-30 | 0.00 | 0.42 | -0.42Net Cash | 0.43 | 0.0% |
| 2023-06-30 | 0.00 | 0.13 | -0.13Net Cash | 0.13 | 0.0% |
| 2023-03-31 | 0.00 | 0.14 | -0.14Net Cash | 0.14 | 0.0% |
| 2022-12-31 | 0.00 | 0.15 | -0.15Net Cash | 0.15 | 0.0% |